- Feb 2019
-
retractionwatch.com retractionwatch.com
-
This isn’t the first time in recent memory that a group of authors has been unhappy that a journal they published in was later delisted. That happened with Oncotarget last year.
To me, this doesn't seem to be a valid reason for retracting the articles. What does COPE say about a case like this? Should the publisher have to remove them?
-
- Oct 2017
-
www.fasebj.org www.fasebj.org
-
"In the ORI report, published Sept. 29, 2017, the agency determined that El-Remessy had “intentionally, knowingly, or recklessly used the same Western blot bands to represent different experimental results” in three papers — a 2005 paper in Journal of Cell Science, a 2013 paper in PLOS ONE, and a 2007 paper in The FASEB Journal. The Journal Cell Science and The FASEB Journal papers have been retracted. The PLOS ONE paper, which has been cited nine times, according to Clarivate Analytics’ Web of Science, has not yet been corrected or retracted."
Tags
Annotators
URL
-
-
journals.plos.org journals.plos.org
-
"In the ORI report, published Sept. 29, 2017, the agency determined that El-Remessy had “intentionally, knowingly, or recklessly used the same Western blot bands to represent different experimental results” in three papers — a 2005 paper in Journal of Cell Science, a 2013 paper in PLOS ONE, and a 2007 paper in The FASEB Journal. The Journal Cell Science and The FASEB Journal papers have been retracted. The PLOS ONE paper, which has been cited nine times, according to Clarivate Analytics’ Web of Science, has not yet been corrected or retracted."
Tags
Annotators
URL
-
-
jcs.biologists.org jcs.biologists.org
-
"In the ORI report, published Sept. 29, 2017, the agency determined that El-Remessy had “intentionally, knowingly, or recklessly used the same Western blot bands to represent different experimental results” in three papers — a 2005 paper in Journal of Cell Science, a 2013 paper in PLOS ONE, and a 2007 paper in The FASEB Journal. The Journal Cell Science and The FASEB Journal papers have been retracted. The PLOS ONE paper, which has been cited nine times, according to Clarivate Analytics’ Web of Science, has not yet been corrected or retracted."
Tags
Annotators
URL
-
- Aug 2017
-
onlinelibrary.wiley.com onlinelibrary.wiley.com
-
Eteplirsen for the treatment of Duchenne muscular dystrophy
Retraction Watch article about this paper can be found here: http://retractionwatch.com/2017/08/21/released-fda-docs-reveal-details-agencys-failed-attempt-retract-paper/
-